HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Sophia Genetics (NASDAQ:SOPH) w

SOPHiA GENETICS (NASDAQ:SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaborati

BOSTON, Oct. 8, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASD

SALT LAKE CITY and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN),

SOPHiA GENETICS SA (NASDAQ: SOPH - Get Free Report) insider Manuela Valente sold 4,240 shares of the

SOPHiA GENETICS SA (NASDAQ: SOPH - Get Free Report) CFO George Cardoza sold 1,592 shares of the comp

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH - Get Free Report) have been assigned a consensus recomme

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Sophia Genetics (NASDAQ:SOPH) wi

BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price

Sophia Genetics (NASDAQ:SOPH) raises FY2026 sales outlook from $92.000 million-$94.000 million to $9

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.30) per share which missed the analys

SOPHiA GENETICS (NASDAQ:SOPH) today announced a new global collaboration to develop, validate, and d

Wall Street analysts change ratings on top stocks. See full changes on analyst ratings page. SCHW, M

Top Wall Street analysts upgraded URBN, GPN, YETI. See what analysts think of SCHW stock.

Top analysts changed outlook on top names. For all changes, incl. upgrades/downgrades/initiations, s

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Sophia Genetics (NAS

(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the st

U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls afte

U.S. stock futures trading higher. CarMax, Sophia Genetics, Jabil, La-Z-Boy, and Safe Bulkers in foc

SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, announced today the

SOPHiA GENETICS (NASDAQ:SOPH), a global leader in Ai-driven precision medicine, today confirmed, ahe

SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understan

Sophia Genetics (NASDAQ:SOPH) affirms FY2026 sales outlook from $92.000 million-$94.000 million to $

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.27) per share which missed the analys

SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced that

BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price

2026 Financial OutlookBased on information as of today, SOPHiA GENETICS is reaffirming the following

SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced the

Guggenheim analyst Subbu Nambi maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the

Executive Transition PlanSOPHiA GENETICS today announced the promotion of Ross Muken to Chief Execut

Full Year 2026 GuidanceBased on information as of today, SOPHiA GENETICS is providing the following

Fourth Quarter 2025 Preliminary Unaudited Financial ResultsRevenue of at least $21 million, represen

BTIG analyst Mark Massaro maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price

- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (NA

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge

Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, and

Sophia Genetics (NASDAQ:SOPH) affirms FY2025 sales outlook from $72.000 million-$76.000 million to $

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.33) per share which missed the analys